table of content
1 Introduction to Research & Analysis Reports
1.1 NSCLC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSCLC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSCLC Drugs Overall Market Size
2.1 Global NSCLC Drugs Market Size: 2022 VS 2029
2.2 Global NSCLC Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NSCLC Drugs Players in Global Market
3.2 Top Global NSCLC Drugs Companies Ranked by Revenue
3.3 Global NSCLC Drugs Revenue by Companies
3.4 Top 3 and Top 5 NSCLC Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies NSCLC Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 NSCLC Drugs Players in Global Market
3.6.1 List of Global Tier 1 NSCLC Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 NSCLC Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NSCLC Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral Type
4.1.3 Injection Type
4.2 By Type - Global NSCLC Drugs Revenue & Forecasts
4.2.1 By Type - Global NSCLC Drugs Revenue, 2018-2023
4.2.2 By Type - Global NSCLC Drugs Revenue, 2024-2029
4.2.3 By Type - Global NSCLC Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NSCLC Drugs Market Size, 2022 & 2029
5.1.2 Squamous Cell Lung Carcinoma
5.1.3 Large-cell Lung Carcinoma
5.2 By Application - Global NSCLC Drugs Revenue & Forecasts
5.2.1 By Application - Global NSCLC Drugs Revenue, 2018-2023
5.2.2 By Application - Global NSCLC Drugs Revenue, 2024-2029
5.2.3 By Application - Global NSCLC Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global NSCLC Drugs Market Size, 2022 & 2029
6.2 By Region - Global NSCLC Drugs Revenue & Forecasts
6.2.1 By Region - Global NSCLC Drugs Revenue, 2018-2023
6.2.2 By Region - Global NSCLC Drugs Revenue, 2024-2029
6.2.3 By Region - Global NSCLC Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America NSCLC Drugs Revenue, 2018-2029
6.3.2 US NSCLC Drugs Market Size, 2018-2029
6.3.3 Canada NSCLC Drugs Market Size, 2018-2029
6.3.4 Mexico NSCLC Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe NSCLC Drugs Revenue, 2018-2029
6.4.2 Germany NSCLC Drugs Market Size, 2018-2029
6.4.3 France NSCLC Drugs Market Size, 2018-2029
6.4.4 U.K. NSCLC Drugs Market Size, 2018-2029
6.4.5 Italy NSCLC Drugs Market Size, 2018-2029
6.4.6 Russia NSCLC Drugs Market Size, 2018-2029
6.4.7 Nordic Countries NSCLC Drugs Market Size, 2018-2029
6.4.8 Benelux NSCLC Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia NSCLC Drugs Revenue, 2018-2029
6.5.2 China NSCLC Drugs Market Size, 2018-2029
6.5.3 Japan NSCLC Drugs Market Size, 2018-2029
6.5.4 South Korea NSCLC Drugs Market Size, 2018-2029
6.5.5 Southeast Asia NSCLC Drugs Market Size, 2018-2029
6.5.6 India NSCLC Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America NSCLC Drugs Revenue, 2018-2029
6.6.2 Brazil NSCLC Drugs Market Size, 2018-2029
6.6.3 Argentina NSCLC Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NSCLC Drugs Revenue, 2018-2029
6.7.2 Turkey NSCLC Drugs Market Size, 2018-2029
6.7.3 Israel NSCLC Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia NSCLC Drugs Market Size, 2018-2029
6.7.5 UAE NSCLC Drugs Market Size, 2018-2029
7 NSCLC Drugs Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck NSCLC Drugs Major Product Offerings
7.1.4 Merck NSCLC Drugs Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb NSCLC Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb NSCLC Drugs Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Regeneron Pharmaceuticals
7.3.1 Regeneron Pharmaceuticals Company Summary
7.3.2 Regeneron Pharmaceuticals Business Overview
7.3.3 Regeneron Pharmaceuticals NSCLC Drugs Major Product Offerings
7.3.4 Regeneron Pharmaceuticals NSCLC Drugs Revenue in Global Market (2018-2023)
7.3.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis NSCLC Drugs Major Product Offerings
7.4.4 Novartis NSCLC Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Jiangsu Hengrui Medicine
7.5.1 Jiangsu Hengrui Medicine Company Summary
7.5.2 Jiangsu Hengrui Medicine Business Overview
7.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Major Product Offerings
7.5.4 Jiangsu Hengrui Medicine NSCLC Drugs Revenue in Global Market (2018-2023)
7.5.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.6 Innovent Biologics
7.6.1 Innovent Biologics Company Summary
7.6.2 Innovent Biologics Business Overview
7.6.3 Innovent Biologics NSCLC Drugs Major Product Offerings
7.6.4 Innovent Biologics NSCLC Drugs Revenue in Global Market (2018-2023)
7.6.5 Innovent Biologics Key News & Latest Developments
7.7 Shanghai Junshi Biosciences
7.7.1 Shanghai Junshi Biosciences Company Summary
7.7.2 Shanghai Junshi Biosciences Business Overview
7.7.3 Shanghai Junshi Biosciences NSCLC Drugs Major Product Offerings
7.7.4 Shanghai Junshi Biosciences NSCLC Drugs Revenue in Global Market (2018-2023)
7.7.5 Shanghai Junshi Biosciences Key News & Latest Developments
7.8 BeiGene
7.8.1 BeiGene Company Summary
7.8.2 BeiGene Business Overview
7.8.3 BeiGene NSCLC Drugs Major Product Offerings
7.8.4 BeiGene NSCLC Drugs Revenue in Global Market (2018-2023)
7.8.5 BeiGene Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche NSCLC Drugs Major Product Offerings
7.9.4 Roche NSCLC Drugs Revenue in Global Market (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca NSCLC Drugs Major Product Offerings
7.10.4 AstraZeneca NSCLC Drugs Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer NSCLC Drugs Major Product Offerings
7.11.4 Pfizer NSCLC Drugs Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
7.12 Boehringer-Ingelheim
7.12.1 Boehringer-Ingelheim Company Summary
7.12.2 Boehringer-Ingelheim Business Overview
7.12.3 Boehringer-Ingelheim NSCLC Drugs Major Product Offerings
7.12.4 Boehringer-Ingelheim NSCLC Drugs Revenue in Global Market (2018-2023)
7.12.5 Boehringer-Ingelheim Key News & Latest Developments
7.13 Teva
7.13.1 Teva Company Summary
7.13.2 Teva Business Overview
7.13.3 Teva NSCLC Drugs Major Product Offerings
7.13.4 Teva NSCLC Drugs Revenue in Global Market (2018-2023)
7.13.5 Teva Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
